
Regulatory tracker: Vertex, NHS England reach reimbursement deal for CF drug Alyftrek
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Be sure to come back regularly …